15 Biggest Mid-Day Losers For Friday

Loading...
Loading...
  • Windtree Therapeutics Inc WINT shares dipped 67.7 percent to $0.275 after the company disclosed top line results for its AEROSURF® phase 2b clinical trial for the treatment of respiratory distress syndrome in premature infants. The company announced that AEROSURF trial did not meet the primary endpoint. Stifel Nicolaus downgraded Windtree Therapeutics from Buy to Hold.
  • Destination Maternity Corp DEST shares declined 32.2 percent to $3.16 after rising 2.18 percent on Thursday.
  • Cara Therapeutics Inc CARA shares tumbled 31.1 percent to $17.58 after the company released concerning top-line results from a phase 2B trial of its oral CR845 therapy for the treatment of pain associated with osteoarthritis of the hip or knee. Janney Capital downgraded Cara Therapeutics from Buy to Neutral.
  • NXT-ID Inc NXTD shares fell 25.4 percent to $2.14.
  • Moleculin Biotech Inc MBRX shares dropped 25.3 percent to $2.22 after declining 9.45 percent on Thursday.
  • Spherix Inc SPEX shares dipped 25.3 percent to $2.93 after surging 105.24 percent on Thursday.
  • MoSys Inc. MOSY shares dipped 20.7 percent to $1.84. MoSys priced 1.325 million shares at $1.70 per share.
  • Cinedigm Corp CIDM shares fell 10.3 percent to $1.83. Cinedigm reported 'significant' strategic investment from Bison Capital. The company entered into a stock purchase agreement to sell Bison 20 million shares for $30 million. Cinedigm also posted Q4 consolidated adjusted EBITDA of $6.7 million, and consolidated revenue of $19.6 million.
  • Exfo Inc EXFO dropped 9 percent to $ 4.55 as the company posted downbeat results for its third quarter and issued a weak forecast for the current quarter.
  • California Resources Corp CRC declined 8.6 percent to $8.57. Bank of America downgraded California Resources from Neutral to Underperform.
  • American Outdoor Brands Corp AOBC shares dropped 7.1 percent to $22.25. American Outdoor Brands reported better-than-expected results for its fourth quarter, but issued a weak outlook for fiscal 2018.
  • Sturm Ruger & Company Inc RGR fell 7 percent to $ 62.70. Sturm, Ruger & Company reported the promotion of Thomas P. Sullivan to Senior Vice President of Operations.
  • Vipshop Holdings Ltd - ADR VIPS declined 6.8 percent to $10.74. Deutsche Bank downgraded Vipshop from Buy to Hold.
  • Re/Max Holdings Inc RMAX dropped 4.4 percent to $55.20. Bank of America downgraded Re/Max from Neutral to Underperform.
  • Micron Technology, Inc. MU slipped 4 percent to $30.20. Micron reported upbeat results for its third quarter and issued a strong forecast for the current quarter.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: NewsMovers & ShakersIntraday UpdateMarketsAnalyst RatingsBiotechnologyHealth CareMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...